Balentine LLC’s GoHealth GOCO Stock Holding History

Balentine LLC’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,016	Closed	-$115K	–	638
2021 Q4	$115K	Buy	+2,016	New	+$135K	﹤0.01%	358

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Balentine LLC's GOCO Position: Q1 2022 in Review

Balentine LLC sold out of GoHealth (GOCO) in Q1 2022, closing a stake of 2,016 shares — an estimated $115K sold.

Balentine LLC first reported a position in GOCO in Q4 2021 and held it in 1 quarter. The position peaked at $115K in Q4 2021. 112 funds tracked by Wall St. Rank hold GOCO as of Q1 2022.

Balentine LLC reported no remaining GoHealth position as of Q1 2022 after selling out during the quarter.
Balentine LLC sold 2,016 GoHealth shares in Q1 2022, an estimated $115K.
Balentine LLC first reported a position in GoHealth in Q4 2021 and held it in 1 quarter.
Balentine LLC's GoHealth position peaked at $115K in Q4 2021.
112 funds tracked by Wall St. Rank held GoHealth as of Q1 2022.

Based on Balentine LLC's 13F filing for Q1 2022, filed 6 May 2022.